Nurix Therapeutics, Inc.NRIXNASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
9.07%
↑ 138% above average
Average (27q)
-23.64%
Historical baseline
Range
High:37.69%
Low:-419.30%
Volatility
-1932.9%
Relatively stable
| Period | Value |
|---|---|
| Q4 2025 | 9.07% |
| Q3 2025 | -89.12% |
| Q2 2025 | 23.13% |
| Q1 2025 | 2.77% |
| Q4 2024 | -18.40% |
| Q3 2024 | -12.51% |
| Q2 2024 | -7.34% |
| Q1 2024 | 0.25% |
| Q4 2023 | -13.30% |
| Q3 2023 | -49.49% |
| Q2 2023 | 37.69% |
| Q1 2023 | 11.78% |
| Q4 2022 | -4.22% |
| Q3 2022 | -2.19% |
| Q2 2022 | -6.95% |
| Q1 2022 | -12.62% |
| Q4 2021 | -30.89% |
| Q3 2021 | -9.78% |
| Q2 2021 | -7.72% |
| Q1 2021 | -22.56% |
| Q4 2020 | -4.25% |
| Q3 2020 | -45.06% |
| Q2 2020 | -5.39% |
| Q1 2020 | 7.45% |
| Q4 2019 | -419.30% |
| Q3 2019 | 18.12% |
| Q2 2019 | -11.15% |
| Q1 2019 | 0.00% |